PE  New Rhein Healthcare Investors

http://www.newrhein.com/





     Office Locations:

77 W. Wacker Drive, Suite 700
Chicago, IL 60601
Phone: 312-899-7942
Fax: 312-899-7965

 

Stages:

  • Late
  • Middle Market


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 2010, New Rhein is a private equity investment firm focused on healthcare therapeutics and medical devices. The firm invests in businesses which utilize proven products in new applications (e.g., new indications, new dosage forms). Products can either be patent protected and branded, non-patent protected and branded, or non-patent protected and non-branded. Companies should generate at least $5M to $50M in revenues and $1M to $10M in operating profit. New Rhein prefers to invest in companies based in Europe, United States, Brazil, and China.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Nayan Gregory Parekh Founder

     

    Portfolio companies include:


      Chase Pharmaceuticals
        web link


      Softhale Sarl


     

    Recent News:


      There is no recent news for New Rhein Healthcare Investors.